Prostacyclin reduces incidence of myocardial damage after coronary endarterectomy

Annals of Thoracic Surgery

Volumn 78, Issue 4, 2004, Pages 1299-1303

  Jonjev, Živojin S ^a,c   Nićin, Svetozar ^a   Mujović, Vujadin ^b   Petrović, Ljuborad ^a   Radovanović, Ninoslav ^a  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

23

Indexed keywords

CREATINE KINASE; PROSTACYCLIN;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; ECG ABNORMALITY; ENDARTERECTOMY; FEMALE; HEART MUSCLE INJURY; HEART VENTRICLE FUNCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; WARMING;

EID: 4644279488     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2004.02.132     Document Type: Article

References (31)

1. Johnson D.W., Flemma R.J., Harding H.W., Cooper G.N.J., Lepley D.J. Surgical principles in the direct reconstruction of left coronary flow. Ann Thorac Surg. 10:1970;141-152
2. Jonjev Z., Redzek A., Radovanovic N. Late results of myocardial revascularization in patients of coronary artery endarterectomy. Med Pregl. 53:2000;373-377
3. Milosevic A. Effect of economic sanctions on incidence, therapy and mortality in acute myocardial infarct at Belgrade clinical centers. Srp Arh Celok Lek. 127:1999;316-318
4. Hahn C., Radovanovic N., Schmuziger M., Hauf E., Faidutti B. Surgical techniques. Cleve Clin Q. 45:1978;83-89
5. Brenowitz J.B., Kayser K.L., Johnson D.W. Triple vessle coronary artery endarterectomy and reconstruction results in 144 patients. J Am Coll Cardiol. 11:1988;706-711
6. Quereshi S.A., Halim M.A., Pillai R., Smith P., Yacoub M.H. Endarterectomy of the left coronary system analysis of a 10 years experience. J Thorac Cardiovasc Surg. 89:1985;852-859
7. Shapira N., Lumia F.J., Gottdiener J.S., Germon P., Lemole G.M. Adjunct endarterectomy of the left anterior descending coronary artery. Ann Thorac Surg. 46:1988;289-296
8. Sundt M.T.I., Camillo J.C., Mendeloff N.E., Barner B.H., Gay A.W. Reappraisal of coronary endarterectomy for the treatment of diffuse coronary artery disease. Ann Thorac Surg. 68:1999;1272-1277
9. Tasdemir O., Kiziltepe U., Karagöz H.Y., Yamak B., Korkmaz S., Bayazit K. Long-term results of reconstruction of the left anterior descending coronary artery in diffuse atherosclerotic lesion. J Thorac Cardiovasc Surg. 112:1996;745-754
10. Grodzinska L., Köning E., Schrör K. Defibrotide is equipotent to urokinase in stimulating arterial and venous trombolysis. Pharmacol Res Comm. 19:1987;609-615
11. Moncada S. Biology and therapeutic potential of prostacyclin. Stroke. 14:1983;157-168
12. Haraldsson Å., Kieler-Jansen N., Wadenvik H., Ricksten S.-E. Inhaled prostacyclin and platelet function after cardiac surgery and cardiopulmonary bypass. Intensive Care Med. 26:2000;188-194
13. Nicin S. Studija primene prostaciklina kao antiagregacionog leka pri operacijama na otvorenom srcu (in Serbian). In: Radovanovic, ed. Novi Sad: University of Novi Sad, Medical School Press, 1989:137-9
14. Addonizio V.P. Jr, Smith J.B., Strauss J.F.I., Colman R.W., Edmunds L.H. Tromboxane synthesis and platelet secretion during cardiopulmonary bypass with bubble oxygenator. J Thorac Cardiovasc Surg. 79:1980;91-96
15. Aherne T., Yee E.S., Gollin G., Ebert P.A. Does prostacyclin (PGI2) cardioplegic infusion improve myocardial protection after ischemic arrest. Ann Thorac Surg. 40:1985;368-373
16. Belch J.J.F., McArdle B., Pllock J.G., et al. Epoprostenol (prostacyclin) and severe arterial disease. Lancet. 8320:1983;315-317
17. Bergman G., Atkinson L., Richardson P.J., Daly K., Rothman M., Jackson G. Prostacyclin. Hemodynamic and metabolic effects in patients with coronary artery disease. Lancet. 8220:1981;569-572
18. DiSesa V.J., Huval W., Lelcuk S., et al. Disatvantages of prostacyclin infusion during cardiopulmonary bypass a double-blind study of 50 patients having coronary revascularization. Ann Thorac Surg. 38:1984;514-519
19. Valentin A., Karnik R., Sehnal E., Slany J. Prostacyclin in peripheral arterial occlusive disease (PAOD) clinical and hemodynamic findings in patients with PAOD stage III and IV. Prog Clin Biol Res. 242:1987;457-462
20. Brener S.J., Lyte B.W., Schneider J.P., Ellis S.G., Topol E.J. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. J Am Coll Cardiol. 40:2002;1967
21. Callif RM, Abdelmeguid AE, Kuntz RE, et al. Myonecrosis after revascularisation procedures. J Am Coll Cardiol 1998:241-51
22. Klatte K., Chaitman B.R., Theroux P., et al. Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoensyme release results from the GUARDIAN trial. J Am Coll Cardiol. 38:2001;1070-1077
23. Aherne T., Price D.C., Yee E.S., Hsieh W.R., Ebert P.A. Prevention of ischemia-induced myocardial platelet deposition by exogenous prostacyclin. J Thorac Cardiovasc Surg. 92:1986;99-104
24. Alpert J.S., Thygesen K., Antman E., Bassand J.P. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 36:2000;959-969
25. Hong M.K., Mehran R., Dangas G., et al. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation. 100:1999;2400-2405
26. Kieler-Jansen N., Milloco I., Kirnö K., Houltz E., Ricksten S.-E. Effect of prostacyclin on myocardial hemodynamics and metabolism after coronary artery bypass grafting. J Cardiothorac Vasc Anesth. 10:2001;741-747
27. Rossoni G., Pompilio G., Biglioli P., et al. Protectant activity of defibrotide in cardioplegia followed by ischemia/reperfusion injury in the isolated rat heart. J Card Surg. 14:1999;334-341
28. Despotis G.J., Joist H.J. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass an update. J Cardiothorac Vasc Anesth. 13:1999;18-29
29. Katircioglu S.F., Kücükaksu D.S., Bodzayi M., Tasdemir O., Bayazit K. Beneficial effect of prostaciclin treatment on reperfusion of the myocardium. Cardiovasc Surg. 3:1995;405-408
30. Asimakopoulos G., Taylor K.M., Ratnatunga C.P. Outcome of coronary endarterectomy a case-control study. Ann Thorac Surg. 67:1999;989-993
31. Jonjev Z.S., Schwertz D.W., Beck J.M., Ross J.D., Law W.R. Subcellular distribution of protein kinase-C isozymes during cardioplegic arrest. J Thorac Cardiovasc Surg. 126:2003;1880-1885